IDENTIFICATION OF THE KEY ROLE OF WHITE MATTER IN THE PATHOGENESIS OF HUNTINGTON'S DISEASE

被引:0
|
作者
Perot, Jean-Baptiste [1 ]
Celestine, Marina [1 ]
Dhenain, Marc [1 ]
Humbert, Sandrine [2 ]
Brouillet, Emmanuel [1 ]
Flament, Julien [1 ]
机构
[1] Univ Paris Saclay, Commissariat Energie Atom & Energies Alternat CEA, Ctr Natl Rech Sci CNRS, Mol Imaging Res Ctr MIRCen,Lab Malad Neurodegener, Fontenay Aux Roses, France
[2] Univ Grenoble Alpes, INSERM, Grenoble Inst Neurosci, Grenoble, France
关键词
D O I
10.1136/jnnp-2021-EHDN.11
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A12
引用
收藏
页码:A4 / A6
页数:3
相关论文
共 50 条
  • [21] White matter connectivity reflects clinical and cognitive status in Huntington's disease
    Poudel, Govinda R.
    Stout, Julie C.
    Dominguez D, Juan F.
    Salmon, Louisa
    Churchyard, Andrew
    Chua, Phyllis
    Georgiou-Karistianis, Nellie
    Egan, Gary F.
    NEUROBIOLOGY OF DISEASE, 2014, 65 : 180 - 187
  • [22] Natural biological variation of white matter microstructure is accentuated in Huntington's disease
    Gregory, Sarah
    Crawford, Helen
    Seunarine, Kiran
    Leavitt, Blair
    Durr, Alexandra
    Roos, Raymund A. C.
    Scahill, Rachael I.
    Tabrizi, Sarah J.
    Rees, Geraint
    Langbehn, Douglas
    Orth, Michael
    HUMAN BRAIN MAPPING, 2018, 39 (09) : 3516 - 3527
  • [23] Progressive alterations in white matter microstructure across the timecourse of Huntington's disease
    Estevez-Fraga, Carlos
    Elmalem, Michael S.
    Papoutsi, Marina
    Durr, Alexandra
    Rees, Elin M.
    Hobbs, Nicola Z.
    Roos, Raymund A. C.
    Landwehrmeyer, Bernhard
    Leavitt, Blair R.
    Langbehn, Douglas R.
    Scahill, Rachael I.
    Rees, Geraint
    Tabrizi, Sarah J.
    Gregory, Sarah
    BRAIN AND BEHAVIOR, 2023, 13 (04):
  • [24] Key role of nuclear medicine in seeking biomarkers of Huntington's disease
    Squitieri, Ferdinando
    Ciarmiello, Andrea
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (06) : 1124 - 1127
  • [25] Key role of nuclear medicine in seeking biomarkers of Huntington’s disease
    Ferdinando Squitieri
    Andrea Ciarmiello
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1124 - 1127
  • [26] Identification of key genes and signaling pathway in the pathogenesis of Huntington's disease via bioinformatics and next generation sequencing data analysis
    Vastrad, Basavaraj
    Vastrad, Chanabasayya
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2025, 26 (01)
  • [27] DISENTANGLING APATHY SUBTYPES IN HUNTINGTON'S DISEASE: A WHITE MATTER BIOMARKER OF DISEASE PROFILE AND PROGRESSION
    De Paepe, Audrey E.
    Sierpowska, Joanna
    Garcia-Gorro, Clara
    Martinez-Horta, Saul
    Perez-Perez, Jesus
    Kulisevsky, Jaime
    Rodriguez-Dechicha, Nadia
    Vaquer, Irene
    Subira, Susana
    Calopa, Matilde
    Munoz, Esteban
    Santacruz, Pilar
    Ruiz-Idiago, Jesus
    Mareca, Celia
    de Diego-Balaguer, Ruth
    Camara, Estela
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A55 - A56
  • [28] The Role of Mutant RNA in the Pathogenesis of Huntington’s Disease and Other Polyglutamine Diseases
    A. N. Bogomazova
    A. V. Eremeev
    G. E. Pozmogova
    M. A. Lagarkova
    Molecular Biology, 2019, 53 : 838 - 849
  • [29] Understanding astrocyte responses to perinatal white matter injury and their role in disease pathogenesis
    Lutz, Amanda Brosius
    Renz, Patricia
    Giovannini-Spinelli, Marialuigia
    Tscherrig, Vera
    Haessler, Valerie
    Liddelow, Shane
    Schoeberlein, Andreina
    Surbek, Daniel
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S310 - S310
  • [30] Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis
    Ayala-Pena, Sylvette
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 62 : 102 - 110